BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21861667)

  • 21. A metabolomic approach to lung cancer.
    Hori S; Nishiumi S; Kobayashi K; Shinohara M; Hatakeyama Y; Kotani Y; Hatano N; Maniwa Y; Nishio W; Bamba T; Fukusaki E; Azuma T; Takenawa T; Nishimura Y; Yoshida M
    Lung Cancer; 2011 Nov; 74(2):284-92. PubMed ID: 21411176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythrocyte membrane phospholipid fatty acid concentrations and risk of colorectal adenomas: a case-control nested in the French E3N-EPIC cohort study.
    Cottet V; Collin M; Gross AS; Boutron-Ruault MC; Morois S; Clavel-Chapelon F; Chajès V
    Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1417-27. PubMed ID: 23704475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct urinary metabolic profile of human colorectal cancer.
    Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
    J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
    Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
    Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.
    Chen L; Zhang C; Gui Q; Chen Y; Yang Y
    Mol Med Rep; 2015 Nov; 12(5):6879-86. PubMed ID: 26352758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: a prospective study.
    Kojima M; Wakai K; Tokudome S; Suzuki K; Tamakoshi K; Watanabe Y; Kawado M; Hashimoto S; Hayakawa N; Ozasa K; Toyoshima H; Suzuki S; Ito Y; Tamakoshi A;
    Am J Epidemiol; 2005 Mar; 161(5):462-71. PubMed ID: 15718482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous measurement of free and esterified fatty acids by gas chromatography from normal and type IV hyperlipoproteinaemic sera.
    Penttilä I; Huhtikangas A; Herranen J; Eskelinen S; Moilanen O
    Ann Clin Res; 1984; 16(1):13-7. PubMed ID: 6742765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker.
    Crotti S; Agnoletto E; Cancemi G; Di Marco V; Traldi P; Pucciarelli S; Nitti D; Agostini M
    Anal Bioanal Chem; 2016 Sep; 408(23):6321-8. PubMed ID: 27379390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chromatomass spectrometric determination of free fatty acids in blood serum].
    Rezvukhin AI; Shalaurova IIu; Potapova IA; Aliab'eva IA
    Vopr Med Khim; 1993; 39(5):55-8. PubMed ID: 8279148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
    Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
    Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS).
    Kim JY; Park JY; Kim OY; Ham BM; Kim HJ; Kwon DY; Jang Y; Lee JH
    J Proteome Res; 2010 Sep; 9(9):4368-75. PubMed ID: 20560578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum biomarkers of colorectal cancer with AU and NP20 chips including a diagnosis model.
    Jin X; Lin M; Zhang H; Han Y; He Y; Zhang Q; Yu S; Chen L; Dong W; Wang W; Sun W; Yin L
    Hepatogastroenterology; 2012; 59(113):124-9. PubMed ID: 22260829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma fatty acids metabolic profiling analysis of coronary heart disease based on GC-MS and pattern recognition.
    Zheng X; Shen J; Liu Q; Wang S; Cheng Y; Qu H
    J Pharm Biomed Anal; 2009 Feb; 49(2):481-6. PubMed ID: 19058943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum fatty acid profiles and potential biomarkers of ankylosing spondylitis determined by gas chromatography-mass spectrometry and multivariate statistical analysis.
    Chen R; Han S; Dong D; Wang Y; Liu Q; Xie W; Li M; Yao M
    Biomed Chromatogr; 2015 Apr; 29(4):604-11. PubMed ID: 25223299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between serum phospholipid fatty acids and dietary intakes assessed a few years earlier.
    Thiébaut AC; Rotival M; Gauthier E; Lenoir GM; Boutron-Ruault MC; Joulin V; Clavel-Chapelon F; Chajès V
    Nutr Cancer; 2009; 61(4):500-9. PubMed ID: 19838922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enrichment of selected serum fatty acids after a small oral dosage of (1-13C)- and (8-13C)triolein in human volunteers analysed by gas chromatography/combustion isotope ratio mass spectrometry.
    Metges CC; Kempe K; Wolfram G
    Biol Mass Spectrom; 1994 May; 23(5):295-301. PubMed ID: 8204686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis.
    Liu L; Li Y; Guan C; Li K; Wang C; Feng R; Sun C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2817-25. PubMed ID: 20846914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.